Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Dentin sialoprotein and phosphophoryn are present in rodent hair follicles and may help hair growth and development.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Female pattern hair loss is more common among Indian women than previously believed.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Higher iron levels in the blood are not linked to increased hair loss in women.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Androgenetic alopecia is a common hair thinning condition linked to genetics and hormones.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Metabolic syndrome reduces effectiveness of hair loss treatment.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

Some women with common hair loss may develop permanent hair loss.

Finasteride can slow hair loss and promote growth in postmenopausal women.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.